BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Novozymes Biopharma 

Castle Court 59 Castle Boulevard

Nottingham    NG7 1FD  United Kingdom
Phone: 44-0115-955-3355 Fax: 44-0115-955-1299


SEARCH JOBS




Industry
Biotechnology






 Company News
Novozymes Biopharma Enters Agreement With A Leading Vaccine Company To Conduct Research On A Novel Subunit Vaccine Complex Based On Albumin Fusion Technology 5/29/2014 10:54:13 AM
Novozymes Biopharma To Offer Drug-Albumin Conjugation Platform In Collaboration With Thiologics 5/13/2014 9:13:07 AM
Novozymes Biopharma Announces Collaboration With Janssen Research & Development To Evaluate Proprietary VELTIS® Half-Life Extension Technology 3/13/2014 9:43:34 AM
Novozymes Biopharma Announces New Data Highlighting Potential For Monthly Drug Dosing 1/27/2014 10:32:10 AM
Novozymes Biopharma Announces Collaboration With Almac Group in Drug Manufacture, Half Life Extension and Targeting Technologies 10/22/2013 8:55:25 AM
Novozymes Biopharma's rAlbumin Approved in Japan as MAQUET Expands Into New Market 2/28/2013 11:36:18 AM
EpiVax, Inc.-Novozymes Biopharma Tregitope-Albumin Fusion Moves "Paradigm-Shifting" Treatment for Diabetes Closer to Clinical Trials 2/12/2013 9:23:05 AM
Novozymes Biopharma Aligns Recombinant Human Albumin Portfolio With New Brand Name 1/29/2013 10:27:43 AM
Novozymes Biopharma Opens Hyaluronic Acid Plant in Tianjin 5/17/2012 10:17:13 AM
Novozymes Biopharma' Ralbumin Supports Faster Time to Market for Neomend Adhesion Barrier Sealant 5/2/2012 9:20:04 AM
123